During an interview, Albert Bourla the CEO of drugmaker Pfizer Inc stated, it is holding talks with the European Union as well as with several member states of the bloc, to sell them its COVID-19 vaccine candidate that is being developed.

“We are negotiating with the EU because that would be much easier. But also we are having extensive discussions with several member states, just in case we can’t find agreement with the EU,” said Bourla.

Categories: Creativity, Entrepreneurship, HR & Organization, Strategy